1. RNA Sequencing in Comparison to Immunohistochemistry for Measuring Cancer Biomarkers in Breast Cancer and Lung Cancer Specimens
    Maxim Sorokin et al, 2020, Biomedicines CrossRef
  2. Performance of 18F-FDG PET/CT Radiomics for Predicting EGFR Mutation Status in Patients With Non-Small Cell Lung Cancer
    Min Zhang et al, 2020, Frontiers in Oncology CrossRef
  3. Imaging Biomarkers of Tumour Proliferation and Invasion for Personalised Lung Cancer Therapy
    Loredana G. Marcu, 2020, Journal of Personalized Medicine CrossRef
  4. Experimental and Meta-Analytic Validation of RNA Sequencing Signatures for Predicting Status of Microsatellite Instability
    Maksim Sorokin et al, 2021, Frontiers in Molecular Biosciences CrossRef
  5. Pathway Instability Is an Effective New Mutation-Based Type of Cancer Biomarkers
    Marianna A. Zolotovskaia et al, 2019, Frontiers in Oncology CrossRef
  6. Gene Expression-Based Signature Can Predict Sorafenib Response in Kidney Cancer
    Alexander Gudkov et al, 2022, Frontiers in Molecular Biosciences CrossRef
  7. Molecular Pathway Activation Markers Are Associated with Efficacy of Trastuzumab Therapy in Metastatic HER2-Positive Breast Cancer Better than Individual Gene Expression Levels
    M. Sorokin et al, 2020, Biochemistry (Moscow) CrossRef

  8. Diagnostic and Predictive Values of 18F-FDG PET/CT Metabolic Parameters in EGFR-Mutated Advanced Lung Adenocarcinoma


    Il Ki Hong et al, 2020, Cancer Management and Research CrossRef
  9. Cancer gene expression profiles associated with clinical outcomes to chemotherapy treatments
    Nicolas Borisov et al, 2020, BMC Medical Genomics CrossRef
  10. Optimal image guidance for tumor biopsy in non-small-cell lung cancer
    Liang Zhao et al, 2020, European Journal of Nuclear Medicine and Molecular Imaging CrossRef
  11. Algorithmically Deduced FREM2 Molecular Pathway Is a Potent Grade and Survival Biomarker of Human Gliomas
    Marianna Zolotovskaia et al, 2021, Cancers CrossRef
  12. Personalized targeted therapy prescription in colorectal cancer using algorithmic analysis of RNA sequencing data
    Maxim Sorokin et al, 2022, BMC Cancer CrossRef
  13. Machine Learning Applicability for Classification of PAD/VCD Chemotherapy Response Using 53 Multiple Myeloma RNA Sequencing Profiles
    Nicolas Borisov et al, 2021, Frontiers in Oncology CrossRef
  14. Recent and current advances in PET/CT imaging in the field of predicting epidermal growth factor receptor mutations in non-small cell lung cancer
    Na Hu et al, 2022, Frontiers in Oncology CrossRef